The at-home injector pen contains a drug called tezepelumab – which blocks a key chemical that triggers attacks – and is more effective than current treatments.
Insiders have told The Mail on Sunday that the treatment is due to be approved by the National Institute for Health and Care Excellence (NICE) later this year following 'dramatic' trial results.
No comments:
Post a Comment